• 

  ELABELA/APELA Levels Are Not Decreased in the Maternal Circulation or Placenta among Women with Preeclampsia. 

  Pritchard, Natasha; Kaitu'u-Lino, Tu'uhevaha J; Gong, Sungsam; Dopierala, Justyna; Smith, Gordon CS; Charnock-Jones, D Stephen; Tong, Stephen (Elsevier BV, 2018-08)

  The genetic deletion of apelin receptor early endogenous ligand (Elabela; official name APELA) produces a preeclampsia-like phenotype in mice. However, evidence linking ELABELA with human disease is lacking. Therefore, we ...
• 

  Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study 

  Smith, GCS; Gaccioli, Francesca; Sovio, Ulla; Cook, Emma; Hund, Martin; Charnock-Jones, D Stephen (Elsevier, 2018-08)

  ABSTRACT Background Fetal growth restriction is a major determinant of perinatal morbidity and mortality. The condition has no gold standard definition but a widely used proxy is delivery of a small for gestational age ...
• 

  Correcting for optimistic prediction in small data sets. 

  Smith, Gordon CS; Seaman, Shaun R; Wood, Angela M; Royston, Patrick; White, Ian R (Oxford University Press (OUP), 2014-08-01)

  The C statistic is a commonly reported measure of screening test performance. Optimistic estimation of the C statistic is a frequent problem because of overfitting of statistical models in small data sets, and methods exist ...
• 

  Universal screening for foetal growth restriction. 

  Smith, Gordon CS (Elsevier BV, 2018-05)

  Foetal growth restriction (FGR) is a major cause of morbidity and mortality. Clinical methods for identifying women whose pregnancies are affected by FGR do not perform well. Despite this, the current approach to screening ...

View more